As Chair of the 2017 ISPE Process Validation Conference, I am pleased to invite you to join us in Bethesda, Maryland, 12 – 14 September to expand your knowledge of the lifecycle approach to process validation.
In addition to case studies and lessons learned that will be presented by your colleagues, the conference offers multiple benchmarking opportunities and interactive exercises to experience application of the practices discussed.
This event will provide you with insight into implementation strategies to meet new expectations and significant changes in the PV lifecycle approach. You’ll find solutions to your most pressing challenges in the various forums with regulatory leaders and industry experts.This year’s conference will cover all stages in the PV lifecycle approach, and delve into areas that present more significant challenges and opportunities, including:
Keynote speakers include:
Additionally, you can sharpen your process validation statistics knowledge by taking advantage of the 2017 ISPE Process Validation Statistics Conference, which takes place right after the Process Validation Conference. Attendees of both conferences will have access to a networking reception and two concurrent evening sessions on 13 September. Save an additional 25% by registering for both conferences.
For more information and to register, please visit www.ISPE.org/2017-Process-Validation-Conference.
We look forward to seeing you in September!
Best Regards
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.
The integration of data science in biopharmaceutical manufacturing, emphasizing data quality, tech transfer efficiency, and process optimization, is the heart of this track. Led by industry experts, discussions explore leveraging digital twins, predictive analytics, and continuous improvement initiatives. Additionally, interactive roundtable discussions provide attendees with a dynamic forum...
The pharmaceutical sector stands at a crossroads of immense possibilities. We are witnessing an unprecedented surge in innovation, fueled by a remarkable partnership between industry and regulatory authorities. For example, there are initiatives fostered by the US Food and Drug Administration (US FDA) to promote innovation with programs such as CATT (CBER Advanced Technologies Team) and ETP...